Skip to content

Paige Prostate

by Paige.Ai

De Novo DEN200080

Paige Prostate is a medical device (FDA Class II; FDA product code QPN, Software Algorithm Device To Assist Users In Digital Pathology) made by Paige.Ai, granted FDA De Novo DEN200080 on 21 Sep 2021, active as of 10 Oct 2026.

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 10 Oct 2026

Documents

Trust

Unverified

Source FDA De Novo, synced 10 Oct 2026.

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN200080 Date21 Sep 2021DecidedStatusActive

Official records

From the FDA record

Received by the FDA
31 Dec 2020
FDA decision
21 Sep 2021
FDA review time
264 days from receipt to decision

From the FDA De Novo record DEN200080 (openFDA), as read on 10 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA product code
QPN
Device class
Class II
Regulation
21 CFR Part 864.3750
Advisory committee
Pathology
FDA decision
DENG De Novo granted

Devices cleared under DEN200080

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under DEN200080
UDI-DISize and differences
Paige Prostate 1.X
Paige.AI, Inc.
1.X00860007599118 —On the market